Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • The ASX small cap stock set for a boost from Amazon Prime Day
    • News

    The ASX small cap stock set for a boost from Amazon Prime Day

    If you haven’t seen the ads that have been peppering Australian television and media over the past week, Amazon Prime Day is coming on June 21 and 22 which means there’s going to be a flurry of retail activity that ASX investors can keep an eye on.  Although Amazon’s entry in the Australian market is

    Read More
    Public
  • Meghan Markle gracefully withdraws from Nobel Prize consideration
    • Satire

    Meghan Markle gracefully withdraws from Nobel Prize consideration

    Following the successful release of her children’s book ‘The Bench’, author Meghan Markle has withdrawn herself from Nobel Prize consideration to give her fellow literary masterminds a level playing field not impacted by her public profile. With the Duchess of Sussex now adding ‘author’ to her decorated career as an actor, producer and now Non-Royal,

    Read More
    Public
  • Family lawsuits booming as AF Legal finalises NSW expansion
    • News

    Family lawsuits booming as AF Legal finalises NSW expansion

    With such an increase in time spent at home over the past year as a result of the pandemic, it seems not all Australians are enjoying each other’s company as evidenced by the rise in filings from family law specialists AF Legal (ASX: AFL). So busy has the firm been, it’s now added large offices

    Read More
    Public
  • Three small cap ASX plodders now positioning for the home straight
    • Opinion

    Three small cap ASX plodders now positioning for the home straight

    Almost every small-cap investor knows the pain of investing in the next big thing, only to find their stock remains resolutely that: a small cap. Or even worse the company ceases to be altogether, providing fodder for the ever-booming insolvency industry. Even more annoying is the regret of investors losing patience with a serial plodder,

    Read More
    Public
  • Spray-on skin revenue exceeds initial forecasts
    • News

    Spray-on skin revenue exceeds initial forecasts

    The inventors of “spray-on skin”, Avita Medical (ASX: AVH) have today released their financial results for the fiscal fourth quarter with the Company reporting strong revenue. The Company was founded to develop and commercialise the RECELL “spray-on skin” product, invented in Perth by Professor Fiona Wood. Professor Wood is a world renowned surgeon and researcher

    Read More
    Public
  • Domestic tourism meets sharing economy as Camplify aims to list with $58m IPO
    • News

    Domestic tourism meets sharing economy as Camplify aims to list with $58m IPO

    While the future on when Aussies can holiday overseas remains unclear, one company is seizing the opportunity that has now become the norm since the pandemic, domestic tourism. Camplify (Proposed ASX code: CHL), is an online platform which connects owners of campervans, caravans, and motorhomes to keen outdoor holidaymakers, renting them out in a similar

    Read More
    Public
  • «
  • ‹
  • 492
  • 493
  • 494
  • 495
  • 496
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.